Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Repealing 2.3% Device Tax Not On Candidate Klobuchar’s '100 Days Plan'

Executive Summary

Democratic presidential candidate Sen. Amy Klobuchar of Minnesota has long been a strong supporter of the medical device industry and has been fighting to repeal the 2.3% medical device excise tax instituted as part of the Affordable Care Act. However, she did not include it as a priority for her administration if she is voted into office in 2020, and seems to be distancing herself from the industry.

You may also be interested in...

Caught In The Crosshairs: What To Do When Congress Comes Knocking

Congressional investigations are harrowing events, if rare, for even the most organized device manufacturer. Speakers at a recent conference discussed how they happen and what strategies may help you get through them.

AdvaMed CEO Discusses 2020 Priorities

Following closely on the heels of a medical device tax repeal win, AdvaMed CEO Scott Whitaker sat down to discuss how the industry advocacy group ended the Obamacare excise tax and what it has in store for 2020.

Device Week, 20 February 2020 – Industry Concerns Grow As Clock Is Running Out On EU MDR

With fewer than a hundred days left before the EU Medical Device Regulations kick in, Medtech Insight’s executive editor Ashley Yeo and managing editor Amanda Maxwell discuss in this week's podcast growing concerns by medtech industry members that they may not be ready in time to comply with the regulations and may inadvertently run afoul of them.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts